Table of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
3.8. Product Pipeline Analysis
3.9. Incidence and Prevalence Analysis
3.10. Patent Analysis
4. TECHNOLOGICAL OUTLOOK
5. SMART BIOMANUFACTURING AND AUTOMATION PLATFORMS MARKET BY COMPONENT
5.1. Introduction
5.2. Hardware
5.3. Software
5.4. Services
6. SMART BIOMANUFACTURING AND AUTOMATION PLATFORMS MARKET BY TECHNOLOGY
6.1. Introduction
6.2. Artificial Intelligence (AI) & Machine Learning (ML)
6.3. Industrial Internet of Things (IIoT)
6.4. Robotics & Automation
6.5. Digital Twin & Simulation
6.6. Cloud Computing & Data Analytics
7. SMART BIOMANUFACTURING AND AUTOMATION PLATFORMS MARKET BY END-USER
7.1. Introduction
7.2. Biopharmaceutical Companies
7.3. Contract Development & Manufacturing Organizations (CDMOs)
7.4. Research Institutes & Academic Labs
7.5. Healthcare & Diagnostic Manufacturers
8. SMART BIOMANUFACTURING AND AUTOMATION PLATFORMS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific
10.2. Sartorius AG
10.3. Danaher Corporation
10.4. Merck KGaA
10.5. Siemens AG
10.6. Agilent Technologies, Inc.
10.7. Waters Corporation
10.8. Eppendorf SE
10.9. Repligen Corporation
10.10. Parker Hannifin Corporation
10.11. Getinge AB
10.12. Lonza Group AG
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations